Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (8): 1-5.doi: 10.6040/j.issn.1671-7554.0.2022.0612
YANG Qifeng, ZHANG Ning
CLC Number:
[1] Giammarile F, Vidal-Si S, Paez D, et al. Sentinel Lymph Node Methods in Breast Cancer [J]. Semin Nucl Med, 2022, S0001-2998(22)00006-X. doi: 10.1053/j.semnuclmed.2022.01.006. [2] Noguchi M, Inokuchi M, Noguchi M, et al. Axillary surgery for breast cancer: past, present, and future [J]. Breast Cancer, 2021, 28(1): 9-15. [3] Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011(Alliance)randomized clinical trial [J]. JAMA, 2017, 318(10): 918-926. [4] Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial [J]. Lancet Oncol, 2007, 8(10): 881-888. [5] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志, 2021, 31(10): 87. [6] Wise J. Breast cancer: NICE recommends innovative magnetic technology for locating sentinel lymph nodes [J]. BMJ, 2022, 377: o1226. doi: 10.1136/bmj.o1226. [7] Vidya R, Khosla M, Laws S, et al. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: the UK SentiMag trial(SMART study)[J]. Surgeon, 2022, S1479-666X(22)00063-4. doi: 10.1016/j.surge.2022.04.006. [8] Micha A, Parvaiz MA, ORiordan L, et al. Isotope-only localization for sentinel lymph node biopsy-medium-term oncological outcomes [J]. Clin Breast Cancer, 2022, 22(5):e636-e640. [9] Zhu Y, Fan X, Yang D, et al. Contrast-enhanced ultrasound for precise sentinel lymph node biopsy in women with early breast cancer:a preliminary study [J]. Diagnostics(Basel), 2021, 11(11):2104. doi: 10.3390/diagnostics11112104. [10] Shimazu K, Miyake T, Tanei T, et al. Real-time visualization of lymphatic flow to sentinel lymph nodes by contrast-enhanced ultrasonography with sonazoid in patients with breast cancer [J]. Ultrasound Med Biol, 2019, 45(10): 2634-2640. [11] Li J, Li H, Guan L, et al. The value of preoperative sentinel lymph node contrast-enhanced ultrasound for breast cancer: a large, multicenter trial [J]. BMC Cancer, 2022, 22(1): 455. doi: 10.1186/s12885-022-09551-y. [12] Zeng HC, Hu JL, Bai JW, et al. Detection of sentinel lymph nodes with near-infrared imaging in malignancies [J]. Mol Imaging Biol, 2019, 21(2): 219-227. [13] Wang Z, Yang X, Wang J, et al. Real-time in situ navigation system with indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer [J]. Front Oncol, 2021, 11: 621914. doi: 10.3389/fonc.2021.621914. eCollection 2021. [14] Li C, Liu P, Shao P, et al. Handheld projective imaging device for near-infrared fluorescence imaging and intraoperative guidance of sentinel lymph node resection [J]. J Biomed Opt, 2019, 24(8): 1-4. [15] Wen S, Liang Y, Kong X, et al. Application of preoperative computed tomographic lymphography for precise sentinel lymph node biopsy in breast cancer patients [J]. BMC Surg, 2021, 21(1): 187. doi: 10.1186/s12893-021-01190-7. [16] Li X, Chen S, Jiang L, et al. Precise intraoperative sentinel lymph node biopsies guided by lymphatic drainage in breast cancer [J]. Oncotarget, 2017, 8(38): 63064-63072. [17] Xu L, Yang J, Du Z, et al. Redefining criteria to ensure adequate sentinel lymph node biopsy with dual tracer for breast cancer [J]. Front Oncol, 2020, 10: 588067. doi: 10.3389/fonc.2020.588067. eCollection 2020. [18] Larson KE, Valente SA, Tu C, et al. Surgeon-associated variation in breast cancer staging with sentinel node biopsy [J]. Surgery, 2018, 164(4): 680-686. [19] Olaya W, Wong J, Wong J, et al. When is a lymph node dissection a lymph node dissection? the number of lymph nodes resected in sentinel and axillary lymph node dissections [J]. Ann Surg Oncol, 2013, 20(2): 627-632. [20] Dutta R, Kluftinger A, Macleod M, et al. Revisiting the “10% rule” in breast cancer sentinel lymph node biopsy: an approach to minimize the number of sentinel lymph nodes removed [J]. Am J Surg, 2012, 203(5): 623-627. [21] Li X, Chen S, Duan Y, et al. Identification and preservation of stained non-sentinel lymph nodes in breast cancer [J]. Oncol Lett, 2020, 20(6): 373. doi: 10.3892/ol.2020.12236. Epub 2020 Oct 21. [22] Li X, Kong X, Chen S, et al. Enlarged para-sentinel lymph node dissection is not necessary in breast cancer patients undergoing sentinel lymph node biopsy [J]. Breast J, 2019, 25(5): 1025-1028. [23] Disipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis [J]. Lancet Oncol, 2013, 14(6): 500-515. [24] Mclaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment [J]. J Clin Oncol, 2020, 38(20): 2341-2350. [25] Ma X, Wen S, Liu B, et al. Relationship between upper extremity lymphatic drainage and sentinel lymph nodes in patients with breast cancer [J]. J Oncol, 2019, 2019: 8637895. doi: 10.1155/2019/8637895.?eCollection 2019. [26] Shao X, Sun B, Shen Y. Axillary reverse mapping(ARM): where to go [J]. Breast Cancer, 2019, 26(1): 1-10. [27] Daniels IR, della Rovere GQ. The axillary arch of Langer - the most common muscular variation in the axilla [J]. Breast Cancer Res Treat, 2000, 59(1): 77-80. [28] Baskin AS, Wang K, Maker AV. Langers arch: an anatomic variant complicating axillary node dissection [J]. Surgery, 2022, S0039-6060(22)00080-0. doi: 10.1016/j.surg.2022.02.001. [29] Sang Y, Kong X, Li X, et al. Langers axillary arch lymph node metastasis in breast cancer patients: A prospective clinical study [J]. Surg Oncol, 2019, 29: 48-52. doi: 10.1016/j.suronc.2019.03.003. Epub 2019 Mar 2. [30] Borm KJ, Ernst L, Voppichler J, et al. Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer [J]. Radiat Oncol, 2022, 17(1): 27. doi: 10.1186/s13014-021-01964-6. |
[1] | Yun LIN,Yanqiu XIE. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46. |
[2] | HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43. |
[3] | ZHAO Tingting, QI Yana, ZHANG Ying, YUAN Bing, HAN Mingyong. Mouse breast cancer induces changes of the microenvironment in pre-metastatic lung tissue [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 24-29. |
[4] | FENG Haigang, LIU Guowen, CAO Hong. Effects and mechanism of interfering MAD2L1 gene expression on the apoptosis of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 9-16. |
[5] | CHU Zhuxiu, ZHAO Wenjing, LI Xiaoyan, KONG Xiaoli, MA Tingting, JIANG Liyu, YANG Qifeng. Significance of neoadjuvant chemotherapy and molecular marker changes in 218 women with breast cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 130-139. |
[6] | WANG Zhe, LIU Yujie, MAO Qian, GUAN Peixia, BAO Qihan, LI Chengsheng, QIAO Xiaowei, PAN Qingzhong, WANG Suzhen. Evaluation of the efficacy of different regimens for early triple negative breast cancer based on the inverse probability of treatment weighting method [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 113-118. |
[7] | LI Wanwan, ZHOU Wenkai, DONG Shuqing, HE Shiqing, LIU Zhao, ZHANG Jiaxin, LIU Bin. Construct of a risk assessment model of breast cancer immune-related lncRNAs based on the database information [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 74-84. |
[8] | KONG Xue, LI Juan, DUAN Weili, SHI Shuang, LI Peilong, DU Lutao, MAO Haiting, WANG Chuanxin. Effects of lncRNA AC012073.1 on the migration and invasion of human breast cancer cells and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 70-78. |
[9] | YOU Xueting, TIAN Xingsong. Analysis of clinicopathological characteristics of 3 514 cases of breast cancer over 9 years [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 49-54. |
[10] | GUO Tian, FU Yilin, GAO Ling, SONG Yongfeng, FU Guobin, GENG Chong, WANG Weibo. Correlation between thyroid hormonal levels and clinical characteristics of 142 women with breast cancer [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 53-59. |
[11] | YANG Xuemei, LI Juan, WANG Yifan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Significance of a three-lncRNAs signature on the prediction of survival for HER2 positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 69-76. |
[12] | LUAN Na, LIU Liyuan, WANG Fei, ZHOU Fei, XIANG Yujuan, HUANG Shuya, ZHENG Chao, YU Lixiang, YU Zhigang. A study of sleep quality of patients with breast cancer and influencing factors [J]. Journal of Shandong University (Health Sciences), 2019, 57(4): 59-64. |
[13] | ZHU Jiujun, JIAO Dechuang, QIAO Jianghua, WANG Lina, MA Youzhao, YANG Yue, LU Zhenduo, LIU Zhenzhen. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 32-37. |
[14] | SHI Aiping, XU Gege, XIE Xinpeng. Review of neoadjuvant therapy for breast cancer at the St.Gallen conference [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 6-11. |
[15] | LI Yi, PENG Jing, ZHANG Lei, LU Jingsong. Effect and mechanism of magnesium isoglycyrrhizinate on the biological behavior of breast cancer cell lines [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 38-44. |
|